MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31

MACROGENICS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$3.33+0.08 (+2.46%)

Close on Oct 19, 2026

Market cap: $211.77M
P/E (TTM): –
Dividend yield: –

MACROGENICS INC cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31
Depreciation & Amortization	7.17	7.54	9.65	12	11	12	12	9.16	7.23	7.61	2.86	1.82	1.20	1.00	1.10
Stock-Based Compensation	14	29	18	20	23	21	20	17	15	12	7.85	3.24	0.86	0.84	2.35
Other Non-Cash Items	0	0.00	-0.42	-2.88	-2.04	0	0	–	–	–	–	–	–	–	–
Change in Accounts Receivable	-9.06	6.06	46	-46	13	-10	17	-16	-11	-1.54	1.71	-0.93	0.04	1.35	13
Change in Inventory	-7.91	-2.19	0.23	0.06	-6.42	0	0	–	–	–	–	–	–	–	–
Change in Accounts Payable	-0.28	-1.53	1.28	-11	7.13	3.72	0.79	1.55	-1.54	2.23	-0.16	-1.50	-0.57	-7.31	-10
Change in Unearned Revenue	-5.40	-9.41	11	49	9.26	-8.47	-21	13	6.53	-4.19	-12	3.32	-17	-11	-4.28
Operating Cash Flow	-81	-68	-78	-87	-144	-112	-134	-153	14	-44	-14	-33	-14	-6.58	6.76
Capital Expenditures	-1.91	-3.71	-1.76	-3.62	-6.20	-5.91	-4.29	-25	-29	-11	-9.20	-3.57	-2.96	-0.94	-0.50
Purchase of Investments	-208	-77	-240	-121	-231	-224	-264	-133	-135	-348	-143	0	0	–	–
Investing Cash Flow	-114	149	-80	71	-37	-7.79	-79	57	78	-70	-152	-3.57	-2.96	-0.94	-0.50
Stock Issued	0	0	0.62	1.09	118	170	119	103	34	0	203	77	85	0.05	0.07
Taxes Paid on Share-Based Awards	-0.29	-2.48	-0.31	0	–	-2.01	0	-0.26	-0.04	-0.04	-0.03	-0.02	0	–	–
Financing Cash Flow	70	0.96	150	1.66	123	174	120	105	35	1.85	204	77	86	0.05	12
Net Change in Cash	-126	82	-7.93	-15	-58	55	-94	8.40	128	-112	39	41	69	-7.48	18
Free Cash Flow	-83	-72	-80	-91	-150	-118	-139	-178	-15	-55	-23	-36	-17	-7.52	6.26
Income Taxes Paid	–	0.94	0	0	–	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 89.2%
Operating margin: -24.3%
Net margin: -8.7%
Return on equity, FY2025: -86.9%

Financial strength

Current ratio: 2.96
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 104.7%

Valuation

P/E ratio: –
Price to sales: 1.26
Price to book: 4.94
Dividend yield: –